Uncategorized
ACADIA Pharmaceuticals to Announce Third Quarter Financial Results on November 5, 2015
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2015 on Thursday, November 5, 2015, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Thursda
